Protalix BioTherapeutics (PLX)
(Real Time Quote from BATS)
$1.14 USD
-0.02 (-1.72%)
Updated Jul 29, 2024 11:56 AM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 32% (81 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | 0.02 | 7.43 | 61.00 |
Year Ago Quarter Estimate | 0.21 | 0.12 | 54.84 |
Next Quarter Estimate | 0.06 | 7.81 | 63.00 |
Next Year Estimate | 0.63 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 33.33 | 15.80 | 15.67 |
Next Year | 425.00 | 10.00 | 9.31 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 29.00 | -2.18 |
Price/Book (MRQ) | 2.86 | 2.09 |
Price/Cash Flow (MRFY) | 8.50 | 16.86 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 11.48% | -54.52% |
Return on Equity (TTM) | 19.48% | -35.38% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.